Detalles de la búsqueda
1.
Determinants of frontline tyrosine kinase inhibitor choice for patients with chronic-phase chronic myeloid leukemia: A study from the Registro Italiano LMC and Campus CML.
Cancer
; 129(17): 2637-2644, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37354090
2.
COVID-19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report.
Br J Haematol
; 196(3): 559-565, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34636033
3.
Next-generation sequencing improves BCR-ABL1 mutation detection in Philadelphia chromosome-positive acute lymphoblastic leukaemia.
Br J Haematol
; 193(2): 271-279, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33403687
4.
Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice.
Haematologica
; 104(8): 1589-1596, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30819917
5.
Outcome of very elderly chronic myeloid leukaemia patients treated with imatinib frontline.
Ann Hematol
; 98(10): 2329-2338, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31392461
6.
Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib.
Int J Mol Sci
; 20(9)2019 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31064152
7.
Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies.
Cancer Invest
; 35(1): 1-22, 2017 Jan 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27996308
8.
Effect of therapeutic plasma exchange on plasma levels of oxidative biomarkers in a patient with thrombotic thrombocytopenic purpura.
Eur J Haematol
; 94(4): 368-73, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24813235
9.
MiRNome expression is deregulated in the peripheral lymphoid compartment of multiple myeloma.
Br J Haematol
; 165(6): 801-13, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24620752
10.
Long term outcome of Ph+ CML patients achieving complete cytogenetic remission with interferon based therapy moving from interferon to imatinib era.
Am J Hematol
; 89(2): 119-24, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24122886
11.
Oxidative Stress and Chronic Myeloid Leukemia: A Balance between ROS-Mediated Pro- and Anti-Apoptotic Effects of Tyrosine Kinase Inhibitors.
Antioxidants (Basel)
; 13(4)2024 Apr 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38671909
12.
The Italian Multicentric Randomized OPTkIMA Trial on Fixed vs Progressive Intermittent TKI Therapy in CML Elderly Patients: 3-Years of Molecular Response and Quality of Life Monitoring After Completing the Treatment Plan.
Clin Lymphoma Myeloma Leuk
; 24(5): 323-331, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38369436
13.
Monoclonal antibodies: potential new therapeutic treatment against multiple myeloma.
Eur J Haematol
; 90(6): 441-68, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23506222
14.
Evaluation of interleukin-23 plasma levels in patients with polycythemia vera and essential thrombocythemia.
Cell Immunol
; 278(1-2): 91-4, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-23121980
15.
Relationship between advanced oxidation protein products, advanced glycation end products, and S-nitrosylated proteins with biological risk and MDR-1 polymorphisms in patients affected by B-chronic lymphocytic leukemia.
Cancer Invest
; 30(1): 20-6, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22236186
16.
Clinical and laboratory features of 103 patients from 42 Italian families with inherited thrombocytopenia derived from the monoallelic Ala156Val mutation of GPIbα (Bolzano mutation).
Haematologica
; 97(1): 82-8, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21933849
17.
Stevens-Johnson syndrome after lenalidomide therapy for multiple myeloma: a case report and a review of treatment options.
Hematol Oncol
; 30(1): 41-5, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21702057
18.
Increase of novel biomarkers for oxidative stress in patients with plasma cell disorders and in multiple myeloma patients with bone lesions.
Inflamm Res
; 61(10): 1063-7, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22674324
19.
Imatinib mesylate therapy induces reduction in neutrophil gelatinase-associated lipocalin serum levels and increase in leptin concentrations in chronic myeloid leukemia patients in molecular remission.
Acta Haematol
; 127(1): 1-6, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-21986252
20.
Treatment-Free Remission in Chronic Myeloid Leukemia Patients Treated With Low-Dose TKIs: A Feasible Option Also in the Real-Life. A Campus CML Study.
Front Oncol
; 12: 839915, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35311109